Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
Puri R, Otaegui I, Sabaté M, Serra-Peñaranda A, Puigfel M, Perez de Prado A, Nombela-Franco L, de la Torre Hernandez JM, Ortas Nadal R, Iniguez-Romo A, Jiménez G, Fernandez-Vazquez F, Cuellas-Ramon C, Gonzalo N, Alfonso Jiménez Diaz V, Duocastella L, Molina M, Amoros M, Perez I, Barria Perez A, Pelletier Beaumont E, Nicholls SJ, Garcia Del Blanco B, Rodés-Cabau J.
Puri R, et al.
Catheter Cardiovasc Interv. 2018 Feb 15;91(3):435-443. doi: 10.1002/ccd.27189. Epub 2017 Jul 14.
Catheter Cardiovasc Interv. 2018.
PMID: 28707379
Clinical Trial.